Visualizing viral transduction of a cocaine-hydrolyzing, human butyrylcholinesterase in rats

Chemico-Biological Interactions

Volumn 157-158, Issue , 2005, Pages 97-103

  Gao, Yang ^a   Brimijoin, Stephen ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cholinesterase immunohistochemistry; Cocaine esterase; Gene transduction; Immunoglobulin M; Reticuloendothelial system; Type 5 adenoviral vector

Indexed keywords

ADENOVIRUS VECTOR; CARBOXYLESTERASE; CHOLINESTERASE; COCAINE; COMPLEMENTARY DNA; IMMUNOGLOBULIN M; THIOCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSDUCTION; HISTOLOGY; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER; LIVER CELL; LIVER PARENCHYMA; LIVER SINUSOID; MALE; MONONUCLEAR CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BUTYRYLCHOLINESTERASE; CARBOXYLIC ESTER HYDROLASES; COCAINE; GENETIC VECTORS; HEPATOCYTES; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA;

EID: 28744433555     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.10.011     Document Type: Conference Paper

References (19)

1. H. Sun, J. El Yazal, S. Brimijoin, and Y.-P. Pang Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase: engineering effective butyrylcholinesterase mutants for cocaine detoxification J. Biol. Chem. 276 2001 9330 9336
2. D.J. Stewart, T. Inaba, B.K. Tang, and W. Kalow Hydrolysis of cocaine in human plasma by cholinesterase Life Sci. 20 1977 1557 1564
3. H. Sun, Y.-P. Pang, O. Lockridge, and S. Brimijoin Re-engineering butyrylcholinesterase as a cocaine hydrolase Mol. Pharmacol. 621 2002 220 224
4. H. Sun, M.L. Shen, Y.-P. Pang, O. Lockridge, and S. Brimijoin Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase JPET 302 2002 710 716
5. Y. Gao, and S. Brimijoin An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats J. Pharmacol. Exp. Ther. 310 2004 1046 1052
6. S. Brimijoin, and O. Lockridge Butyrylcholinesterase and cocaine E. Giacobini Butyrylcholinesterase: Its Function and Inhibitors 2003 Martin Dunitz London 101 111
7. C.E. Thomas, E. Atanasova, and M.A. Kay Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4 2003 346 358
8. B.P. Doctor Butyrylcholinesterase: its use for prophylaxis of organophosphate exposure E. Giacobini Butyrylcholinesterase: Its Function and Inhibitors 2003 Martin Dunitz London 163 177
9. J.D. Pancook, G. Pecht, M. Ader, M. Mosko, O. Lockridge, and J.D. Watkins Application of directed evolution technology to optimize the cocaine hydrolase activity of human butyrylcholinesterase FASEB J. 17 2003 A565
10. Y. Gao, E. Atanasova, S. Nan, J.D. Pancook, J.D. Watkins, and S. Brimijoin Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats Mol. Pharm. 67 2005 204 211
11. G.B. Koelle, and J.S. Friedenwald A histochemical method for localizing cholinesterase activity Proc. Soc. Exp. Biol. Med. 70 1949 617 622
12. S. Brimijoin, K.P. Mintz, and M. Alley Production and characterization of separate monoclonal antibodies to human acetylcholinesterase and butyrylcholinesterase Mol. Pharmacol. 24 1983 513 520
13. B. Li, J.A. Stribley, A. Ticu, W. Xie, L.M. Schopfer, P. Hammond, S. Hinrichs, and O. Lockridge Abundant tissue butyrylcholinesterase and its possible function in the acetylcholineterase knockout mouse J. Neurochem. 75 2000 1320 1331
14. V. Shah, A. Chen, H. Hendrickson, D. Weiler, L. Smith, J. Yao, and Z. Katusic Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro Am. J. Physiol. Gastrointest. Liver Physiol. 279 2000 G1023 G1030
15. S. Connelly, and C. Mech Delivery of adenoviral DNA to mouse liver Methods Mol. Biol. 246 2004 37 52
16. D. Grimm, and M.A. Kay From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy Curr. Gene Ther. 3 2003 281 304
17. O. Lockridge, R.M. Blong, and P. Masson A single amino acid substitution, Gly117His, confers phosphotriesterase activity on human butyrylcholinesterase Biochemistry 36 1997 786 795
18. C.B. Millard, O. Lockridge, and C.A. Broomfield Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase Biochemistry 37 1998 237 247
19. J. Jakobsson, C. Ericson, M. Jansson, E. Björk, and C. Lundberg Targeted transgene expression in rat brain using lentiviral vectors J. Neurosci. Res. 73 2003 876 885